NO20090067L - Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer - Google Patents

Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer

Info

Publication number
NO20090067L
NO20090067L NO20090067A NO20090067A NO20090067L NO 20090067 L NO20090067 L NO 20090067L NO 20090067 A NO20090067 A NO 20090067A NO 20090067 A NO20090067 A NO 20090067A NO 20090067 L NO20090067 L NO 20090067L
Authority
NO
Norway
Prior art keywords
pharmaceutical combinations
treatment
respiratory diseases
drugs
compounds
Prior art date
Application number
NO20090067A
Other languages
English (en)
Inventor
Andreas Schnapp
Ingo Konetzki
Sabine Pestel
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20090067L publication Critical patent/NO20090067L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Foreliggende oppfinnelse angår nye farmasøytiske kombinasjoner som inneholder i tillegg til én eller flere, fortrinnsvis én forbindelse med den generelle formel 1 1 hvor gruppene R1, R2 og R3 kan ha betydningene gitt i kravene og spesifikasjonen, minst én videre aktiv substans 2, metoder for fremstilling av dem og anvendelse av dem som medikamenter.
NO20090067A 2006-08-22 2009-01-06 Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer NO20090067L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119272 2006-08-22
PCT/EP2007/058653 WO2008023003A1 (de) 2006-08-22 2007-08-21 Arzneimittelkombinationen zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
NO20090067L true NO20090067L (no) 2009-03-17

Family

ID=38535607

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090067A NO20090067L (no) 2006-08-22 2009-01-06 Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer

Country Status (20)

Country Link
US (1) US20080051392A1 (no)
EP (1) EP2094271A2 (no)
JP (1) JP2010501521A (no)
KR (1) KR20090047539A (no)
CN (1) CN101505757A (no)
AR (1) AR062475A1 (no)
AU (1) AU2007287536A1 (no)
BR (1) BRPI0715855A2 (no)
CA (1) CA2661496A1 (no)
CO (1) CO6150168A2 (no)
EA (1) EA200900269A1 (no)
EC (1) ECSP099080A (no)
IL (1) IL197125A0 (no)
MX (1) MX2009001355A (no)
NO (1) NO20090067L (no)
PE (1) PE20081358A1 (no)
TW (1) TW200817009A (no)
UY (1) UY30552A1 (no)
WO (1) WO2008023003A1 (no)
ZA (1) ZA200810828B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
NO166268C (no) * 1985-07-30 1991-07-03 Glaxo Group Ltd Innretning for administrering av medikamenter til pasienter.
CA2534125A1 (en) * 2003-07-29 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
DE102004048390A1 (de) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones

Also Published As

Publication number Publication date
CN101505757A (zh) 2009-08-12
BRPI0715855A2 (pt) 2013-07-30
IL197125A0 (en) 2009-11-18
CO6150168A2 (es) 2010-04-20
WO2008023003A1 (de) 2008-02-28
WO2008023003A8 (de) 2008-05-22
KR20090047539A (ko) 2009-05-12
EP2094271A2 (de) 2009-09-02
AU2007287536A1 (en) 2008-02-28
AR062475A1 (es) 2008-11-12
PE20081358A1 (es) 2008-10-31
TW200817009A (en) 2008-04-16
CA2661496A1 (en) 2008-02-28
MX2009001355A (es) 2009-02-13
UY30552A1 (es) 2008-03-31
US20080051392A1 (en) 2008-02-28
EA200900269A1 (ru) 2009-08-28
ECSP099080A (es) 2009-02-27
ZA200810828B (en) 2009-11-25
JP2010501521A (ja) 2010-01-21

Similar Documents

Publication Publication Date Title
NO20082709L (no) Kjemiske forbindelser
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
NO20074703L (no) Antibakterielle piperidinderivater
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20073719L (no) Kjemiske forbindelser
NO20071776L (no) Kinoksaliner som B RAF inhibitorer.
NO20054414L (no) Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner
NO20092342L (no) Azaspiroderivativater
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
NO20085176L (no) Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter
NO20074647L (no) 3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere
NO20064584L (no) Tetrahydropyridoindolderivater
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
TW200616974A (en) Chemical compounds
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NO20076195L (no) Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
TW200621259A (en) Chemical compounds
NO20082269L (no) Nye piperaziner som antimalariamidler
NO20092691L (no) 4-hydroksy-2-okso-2,3-dihydro-1,3-benzotiazol-7yl-forbindelser for modulering av B2-adrenoreseptoraktivitet
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application